Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Protara Therapeutics, Inc. (TARA) Gross Margin data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-40.42M |
|
-- |
|
-- |
|
$43.61M |
|
$-43.61M |
|
$3.19M |
|
$-40.42M |
|
$-40.42M |
|
$-40.42M |
|
$-40.42M |
|
$-40.42M |
|
$-40.42M |
|
$-43.61M |
|
$-42.70M |
|
11.33M |
|
11.33M |
|
$-3.57 |
|
$-3.57 |
|
| Balance Sheet Financials | |
$68.70M |
|
$1.30M |
|
$10.25M |
|
$78.95M |
|
$6.15M |
|
-- |
|
$4.48M |
|
$10.63M |
|
$68.32M |
|
$68.32M |
|
$68.32M |
|
11.37M |
|
| Cash Flow Statement Financials | |
$-37.56M |
|
$53.11M |
|
$-0.09M |
|
$24.87M |
|
$40.33M |
|
$15.46M |
|
$6.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.16% |
|
-59.16% |
|
-51.19% |
|
-59.16% |
|
$6.01 |
|
$-3.32 |
|
$-3.31 |
|